Domestic synthesis under cGMP conditions implies standardized equipment calibration, environmental controls, documented procedures, and quality management systems
The majority of the reports described patients mistakenly drawing up more than the prescribed dose from a multiple-dose vial during self-administration, the FDA said
Require FDA-approved brand-name medication specifically and upfront
Peripheral neuropathy (with unregulated products): The WHO has received reports linking nerve damage to high-dose IV glutathione administered without adequate medical oversight, primarily in markets with unregulated products
1mL), which can reduce irritation
Assess the patients visual acuity, fine motor coordination, and cognitive abilities to determine the appropriate SMBG method